Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSPYL: 18F-DCFPyL PET/CT in Prostate Cancer
NCT04390880Phase 2Completed
- Sponsor
- VA Greater Los Angeles Healthcare System
- Start
- Apr 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of piflufolastat f 18 in prostate cancer (PCa), sponsored by VA Greater Los Angeles Healthcare System. Started Apr 2020; status: completed.
02
Drugs
piflufolastat f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04390880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04390880.